NOVEL APPROACHES FOR THE USE OF AMINOGLYCOSIDES - THE VALUE OF EXPERIMENTAL-MODELS

被引：27

作者：

KAPUSNIK, JE

SANDE, MA

机构：

[1] UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143

[2] SAN FRANCISCO GEN HOSP,SAN FRANCISCO,CA 94110

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1986年 / 17卷

关键词：

D O I：

10.1093/jac/17.suppl_A.7

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

收藏

页码：7 / 10

页数：4

相关论文

共 16 条

[1] INFLUENCE OF DOSAGE REGIMEN ON EXPERIMENTAL GENTAMICIN-NEPHROTOXICITY - DISSOCIATION OF PEAK SERUM LEVELS FROM RENAL-FAILURE
BENNETT, WM
PLAMP, CE
GILBERT, DN
PARKER, RA
PORTER, GA
[J]. JOURNAL OF INFECTIOUS DISEASES, 1979, 140 (04) : 576 - 580
[2] GENTAMICIN BLOOD-LEVELS - GUIDE TO NEPHROTOXICITY
DAHLGREN, JG
ANDERSON, ET
HEWITT, WL
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1975, 8 (01) : 58 - 62
[3] DRAKE TA, 1986, ANTIMICROBIAL AGENTS
[4] GORDIN F, 1984, 24TH INT C ANT AG CH, P178
[5] GENTAMICIN SERUM CONCENTRATIONS - PHARMACOKINETIC PREDICTIONS
HULL, JH
SARUBBI, FA
[J]. ANNALS OF INTERNAL MEDICINE, 1976, 85 (02) : 183 - 189
[6] KAPUSNIK JE, 1985, CLIN RES, V33, pA57
[7] SINGLE-DOSE DAILY GENTAMICIN THERAPY IN URINARY-TRACT INFECTION
LABOVITZ, E
LEVISON, ME
KAYE, D
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1974, 6 (04) : 465 - 470
[8] LUFT F C, 1983, Reviews of Infectious Diseases, V5, pS268
[9] EXPERIENCE IN MONITORING GENTAMICIN THERAPY DURING TREATMENT OF SERIOUS GRAM-NEGATIVE SEPSIS
NOONE, P
PARSONS, TMC
PATTISON, JR
SLACK, RCB
GARFIELD.D
HUGHES, K
[J]. BRITISH MEDICAL JOURNAL, 1974, 1 (5906) : 477 - 481
[10] PECHERE JC, 1984, 24TH INT C ANT AG CH, P178